CSF3 and breast carcinoma: Recently, a prospective randomized trial was presented at ASCO 2020, comparing ciprofloxacin prophylaxis with G-CSF support during adjuvant chemotherapy in patients with early stage breast cancer, showing lower rates of febrile neutropenia and a trend for reduced hospitalizations in patients receiving G-CSF [21].